ResMed sues Respironics for mask patent infringment.
Peter C. Farrell, Ph.D., ResMed's Chairman and Chief Executive Officer, commented, "ResMed has devoted substantial resources to the development of its mask technology. The suit is an effort to protect the intellectual property those resources have produced. We will not tolerate the copying of our products by competitors."
ResMed is a leading developer, manufacturer, and marketer of medical equipment for the diagnosis, treatment and management of sleep-disordered breathing, selling a comprehensive range of products in over 60 countries.
ResMed Inc. +1-858-746-2211 www.resmed.com
|Printer friendly Cite/link Email Feedback|
|Publication:||BIOTECH Patent News|
|Article Type:||Brief Article|
|Date:||Oct 1, 2002|
|Previous Article:||Neurocrine and Taisho restructure diabetes agreement.|
|Next Article:||Introgen obtains patent for p53 targeted chemotherapy.|
|Philips Electronics expands medical device portfolio with $5.1 billion Respironics deal.|